Q2 2022 Heron Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen and thank you for standing by. Welcome to the Heron Therapeutics Q2 2022 Earnings Conference. (Operator Instructions)
Now I would like to turn the call over to David Szekeres, Executive Vice President, Chief Operating Officer. Please proceed.
Good afternoon, everyone and thank you for joining us. With me today from here are Barry Quart, Chief Executive Officer and Chairman and John Poyhonen, President and Chief Commercial Officer. For those of you participating via conference call, the slides are made available via webcast and can also be accessed by going to the Investor Relations page of our website following conclusion of today's call.
Before we begin, I would like to remind you that this call will contain forward-looking statements concerning Heron's future expectations, plans, prospects, corporate strategy and performance, which constitute forward-looking statements for the purposes of the safe harbor provision under the Private Securities
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

